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STUDY QUESTION: Is the rate and nature of chromosome instability (CIN) similar between bovine in vivo-derived and in vitro-cultured
cleavage-stage embryos?
SUMMARY ANSWER: There is a major difference regarding chromosome stability of in vivo-derived and in vitro-cultured embryos, as CIN
is significantly lower in in vivo-derived cleavage-stage embryos compared to in vitro-cultured embryos.
WHAT IS KNOWN ALREADY: CIN is common during in vitro embryogenesis and is associated with early embryonic loss in humans, but
the stability of in vivo-conceived cleavage-stage embryos remains largely unknown.
STUDY DESIGN, SIZE, DURATION: Because human in vivo preimplantation embryos are not accessible, bovine (Bos taurus) embryos
were used to study CIN in vivo. Five young, healthy, cycling Holstein Friesian heifers were used to analyze single blastomeres of in vivo
embryos, in vitro embryos produced by ovum pick up with ovarian stimulation (OPU-IVF), and in vitro embryos produced from in vitromatured
oocytes retrieved without ovarian stimulation (IVM-IVF).
PARTICIPANTS/MATERIALS, SETTING, METHODS: Single blastomeres were isolated from embryos, whole-genome amplified
and hybridized on Illumina BovineHD BeadChip arrays together with the bulk DNA from the donor cows (mothers) and the bull (father).
DNA was also obtained from the parents of the bull and from the parents of the cows (paternal and maternal grandparents, respectively).
Subsequently, genome-wide haplotyping and copy-number profiling was applied to investigate the genomic architecture of 171 single bovine
blastomeres of 16 in vivo, 13 OPU-IVF and 13 IVM-IVF embryos.
MAIN RESULTS AND THE ROLE OF CHANCE: The genomic stability of single blastomeres in both of the in vitro-cultured embryo
cohorts was severely compromised (P < 0.0001), and the frequency of whole chromosome or segmental aberrations was higher in embryos
†These authors are contributed equally to this work.
© The Author 2017. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved.
For Permissions, please e-mail: journals.permissions@oup.com
D
ow
nloaded from
 https://academ
ic.oup.com
/hum
rep/article-abstract/32/11/2348/4191354 by ELN
ET G
roup Account user on 26 February 2019
produced in vitro than in embryos derived in vivo. Only 18.8% of in vivo-derived embryos contained at least one blastomere with chromosomal
anomalies, compared to 69.2% of OPU-IVF embryos (P < 0.01) and 84.6% of IVM-IVF embryos (P < 0.001).
LARGE SCALE DATA: Genotyping data obtained in this study has been submitted to NCBI Gene Expression Omnibus (GEO; accession
number GSE95358)
LIMITATIONS REASONS FOR CAUTION: There were two main limitations of the study. First, animal models may not always reflect
the nature of human embryogenesis, although the use of an animal model to investigate CIN was unavoidable in our study. Second, a limited
number of embryos were obtained, therefore more studies are warranted to corroborate the findings.
WIDER IMPLICATIONS OF THE FINDINGS: Although CIN is also present in in vivo-developed embryos, in vitro procedures exacer-
bate chromosomal abnormalities during early embryo development. Hence, the present study highlights that IVF treatment compromises
embryo viability and should be applied with care. Additionally, our results encourage to refine and improve in vitro culture conditions and
assisted reproduction technologies.
STUDY FUNDING/COMPETING INTEREST(S): The study was funded by the Agency for Innovation by Science and Technology
(IWT) (TBM-090878 to J.R.V. and T.V.), the Research Foundation Flanders (FWO; G.A093.11 N to T.V. and J.R.V. and G.0392.14 N to A.V.
S. and J.R.V.), the European Union’s FP7 Marie Curie Industry-Academia Partnerships and Pathways (IAPP, SARM, EU324509 to J.R.V., T.V.,
O.T, A.D., A.S. and A.K.) and Horizon 2020 innovation programme (WIDENLIFE, 692065 to J.R.V., O.T., T.V., A.K. and A.S.). M.Z.E., J.R.V.
and T.V. are co-inventors on a patent application ZL913096-PCT/EP2014/068315-WO/2015/028576 (‘Haplotyping and copy-number typ-
ing using polymorphic variant allelic frequencies’), licensed to Cartagenia (Agilent Technologies).
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Introduction
Infertility is a rising health problem that leads to reduced fecundity
rates in developed countries. As a consequence, more couples turn to
ART to overcome childlessness and age-related infertility (Dyer et al.,
2016). On the other hand, the increased access to ART provides the
opportunity for more couples to better plan and manage pregnancies.
Since the birth of the first ‘test tube baby’ (Steptoe and Edwards,
1978), over 6 million children have been conceived via ART and fertil-
ity treatments have become standard care in many countries
(Maheshwari et al., 2016). Despite the progress made in clinical and
laboratory ART protocols, including embryo selection for transfer, the
pregnancy rate per embryo transfer after ART still lingers at around
30% worldwide (Dyer et al., 2016).
Embryonic chromosomal aneuploidy is a major factor contributing
to embryo implantation failure as well as spontaneous miscarriage and
may explain the relatively low success rate of IVF procedures
(Vanneste et al., 2009b). Studies on human IVF preimplantation
embryos have revealed a remarkably high incidence of chromosomal
instability (CIN) with 70–90% of cleavage-stage embryos carrying at
least one aneuploid cell (Vanneste et al., 2009a, b; Voet et al., 2011;
Chow et al., 2014; Huang et al., 2014; Zamani Esteki et al., 2015).
Moreover, terminal deletions and duplications are also found in natur-
ally conceived newborns (Riegel et al., 2001). In addition, several cases
of mosaic individuals, exhibiting mixoploidy or chimaerism have also
been well documented (Jarvela et al., 1993; Edwards et al., 1994;
Yamazawa et al., 2010). Therefore, we hypothesized that CIN would
also occur at similar rate in vivo. Due to the ethical and legal constraints
associated with human embryo research, naturally conceived human
cleavage-stage embryos are not accessible, and CIN in human IVF and
in vivo embryos cannot be compared directly. As an alternative, animal
models have been widely used for investigating chromosomal abnor-
malities in in vivo and in vitro preimplantation embryos (Viuff et al.,
2001; Rambags et al., 2005; Coppola et al., 2007). However, the major
limitation of previous studies was the application of low-resolution kar-
yotyping methods that can neither detect CIN at the single-cell level
nor reveal subtle sub-chromosomal aberrations. Thus, the knowledge
about the genomic stability of in vivo-conceived embryos remained lim-
ited, largely due to the lack of robust genome analysis technologies.
To compare in vitro versus in vivo CIN directly, we used bovine
cleavage-stage embryos, which represent a suitable model mimicking
human early embryogenesis (Menezo and Herubel, 2002; Destouni
et al., 2016). In addition, similarly to human only 40–55% of dairy cows
produce an offspring after single insemination (Diskin et al., 2012), and
aneuploidy was reported in one-fifth of bovine aborted fetuses and
non-viable neonates (Coates et al., 1988). We applied a genome-wide
single-cell analysis method that enabled haplotyping and copy-number
profiling, called haplarithmisis (Zamani Esteki et al., 2015), on all
individual bovine blastomeres obtained from in vivo embryos derived
from oocytes that were matured and fertilized in vivo after ovarian
stimulation of donor animals (referred to as in vivo embryos). In
parallel, we tested in vitro-produced embryos derived from in vitro
matured and fertilized oocytes that were retrieved from the same
donor animals using ovarian stimulation and ovum pick up (referred
to as OPU-IVF embryos) and in vitro-produced embryos derived
from in vitro matured and fertilized oocytes that were retrieved from
donor animals without ovarian stimulation (referred to as IVM-IVF
embryos). All single blastomeres were analyzed for the presence of
chromosomal aberrations.
Materials andMethods
Ethical approval
This study was approved by the Ethical Committee of the Faculty of Veterinary
Sciences of Ghent University, Belgium (EC2013/197, EC2015/71).
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Study design
The aim of the study was to evaluate CIN in naturally conceived preim-
plantation embryos. In parallel, we investigated the influence of different
IVF procedures on embryo development using bovine as a model for
human early embryogenesis (Menezo and Herubel, 2002; Destouni et al.,
2016). Five young, healthy, cycling Holstein Friesian heifers (Bos taurus)
between 18 and 36 months of age were used as oocyte and embryo
donors. All donor cows were subjected to hormonal stimulation with sub-
sequent ovum pick up or in vivo embryo collection (Besenfelder et al.,
2008). Blood samples from the donor cows (mothers) and semen from
the bull (father) were used to extract bulk DNA (DNeasy Blood and
Tissue kit, Qiagen, Germany). Bulk DNA was also obtained from the par-
ents of the bull (paternal grandparents) and the available parents of the
cows (maternal grandparents; only for crosses 4757, 8301 and 9617).
After hormonal treatments, the cows were left untreated for one month
before they were slaughtered. After collection of ovaries, oocytes were
retrieved and embryos were produced in vitro by routine procedures
(Catteeuw et al., 2017). Subsequently, single blastomeres were isolated,
whole-genome amplified (WGA) and hybridized on BovineHD BeadChip
arrays (Illumina Inc., USA). The acquired array data was used for single-cell gen-
ome-wide haplotyping and copy-number profiling (Zamani Esteki et al., 2015).
Media and reagents
Basic Eagle’s Medium amino acids, Minimal Essential Medium (MEM) non-
essential amino acids (100×), TCM-199-medium, kanamycin and gentamy-
cin were purchased from Life Technologies Europe (Ghent, Belgium) and
all other components were obtained from Sigma (Schnelldorf, Germany),
unless otherwise stated. All the media were filter-sterilized using a 0.22
μm filter (Pall Corporation, Ann Arbor, MI, USA) before use.
Stimulation protocol and ovum pick up
Stimulation protocol for ovum pick up was used to generate OPU-IVF
embryos and was performed 3 to 6 times in all animals with at least one
week interval between OPU sessions. On Day 0, heifers were given an epi-
dural anesthesia using 3 ml of Procaine Hydrochloride 2% (VMD, Belgium)
to decrease peristalsis and discomfort. An ultrasound probe was inserted
in the vagina, and follicles larger than 5 mm were removed by puncturing
the ovaries. Animals received dinoprost (prostaglandin F2α (PGF2α)) intra-
muscularly (i.m.) (Dinolytic
®
, Zoetis, Belgium), and a CIDR (controlled
internal drug release, Progesterone, Zoetis, Belgium) was administered in
the vagina. In following days, pFSH injections (Stimufol
®
, Reprobiol,
Belgium) were given i.m. twice a day. The CIDR was removed 40–44 h
after the last pFSH injection and OPU was performed. On the day of OPU
animals were given an epidural anesthesia using 3 ml of Procaine
Hydrochloride 2%. All follicles were aspirated using an ultrasound probe, a
7.5 MHz transducer and a stainless steel guide. Puncturing was performed
using disposable 19 G needles connected to a 50 ml tube via silicon tubing.
Needles were changed between ovaries of the same animal and between
animals, further tubing was also renewed between animals. Follicular fluid
containing the oocytes was collected in 5 ml HEPES-buffered TCM-199
supplemented with 18 IU/ml heparin, 50 μg/ml gentamicin and 0.1% fetal
calf serum (FCS). Immediately following recovery, the collected follicular
fluid was filtered through a 75 μm mesh filter with HEPES-buffered TCM-
199. Oocytes were grouped per donor and embryos were produced
according to the standard in vitro embryo production protocol.
In vitro bovine embryo production protocol
Bovine OPU-IVF and IVM-IVF embryos were produced per donor by pre-
viously described methods (Catteeuw et al., 2017). Briefly, oocytes
retrieved via ovum pick up and oocytes retrieved from ovaries of
slaughtered animals were placed per donor in 500 μl maturation medium,
consisting of modified bicarbonate-buffered TCM-199 supplemented with
50 μg/ml gentamycin and 20 ng/ml epidermal growth factor (EGF) for
22 h at 38.5°C in 5% CO2 in humidified air. After maturation, frozen–
thawed semen of a previously tested Holstein Friesian bull was used for
fertilization. Spermatozoa were separated over a discontinuous Percoll
gradient (45 and 90%; GE Healthcare Biosciences, Uppsala, Sweden) and
sperm concentration was adjusted to 1 × 106 spermatozoa/ml using IVF-
TALP (Tyrode’s Albumin Lactate Pyruvate), which is supplemented with
6 mg/ml BSA (Sigma A8806) and 25 μg/ml heparin. Matured oocytes
were incubated per donor in 500 μl IVF-TALP with spermatozoa for 21 h
at 38.5°C in 5% CO2 in humidified air. Presumptive zygotes were trans-
ferred to synthetic oviductal fluid (SOF) supplemented with essential and
non-essential amino acids (SOFaa), 0.4% BSA (Sigma A9647) and ITS
(5 μg/ml insulin, 5 μg/ml transferrin and 5 ng/ml selenium) and were
placed per donor in a droplet of culture medium. The droplet size differed
between donors depending on the number of zygotes, an embryo:medium
ratio of 1:2 was maintained with a minimal droplet size of 20 μl. Each drop-
let was covered by mineral oil and incubated at 38.5°C in 5% CO2, 5% O2
and 90% N2.
Oviductal flush and collection of in vivo
embryos
The in vivo collection of embryos was performed by oviductal flush as
described earlier (Besenfelder et al., 2008). First, estrous cycles of the
donor animals were pre-synchronized by i.m. administering 2 ml PGF2α
(500 μg Cloprostenol, Estrumate, Belgium) twice within 11 days. Forty-
eight hours after both PGF2α treatments, the animals received i.m. About
21 μg Gonadotropin Releasing Hormone (GnRH) (Receptal
®
, MSD AH,
Belgium). Dominant follicles were ablated 9 days after heat detection.
Thirty-six hours later, pFSH was administered in decreasing dosages twice
a day for 4 days (1.5, 1.4, 1.2, 1.1, 0.8, 0.6, 0.5 and 0.5 ml), and in total
380 μg follitropine was given. The donor animals received two PGF2α
treatments 60 and 72 h after the initial pFSH treatment. Finally, 24 h after
the last pFSH treatment, 21 μg GnRH was administered to induce ovula-
tion, simultaneously animals were inseminated with frozen–thawed semen.
Artificial insemination (AI) was repeated 12 and 24 h later. Embryos were
flushed bilaterally 36 h after the last AI. Briefly, donor animals were given
epidural anesthesia using 5 ml of Procaine Hydrochloride 2%. An embryo
flushing catheter was directed through the cervix and fixed in the uterine
horn. An integrated device consisting of a universal tube, an endoscope
and flushing system was inserted through the vaginal wall into the periton-
eal cavity, which was passively filled with air. Oviducts were flushed with
40–60 mL flushing medium (PBS supplemented with 1% FCS) to pass the
embryos through the uterotubal junction. Once in the uterine horn, flush-
ing medium containing the embryos was collected via the uterus flushing
catheter into an embryo filter. Finally, the uterine horn was flushed with
another 300–500 mL medium through the uterine flushing catheter. This
procedure was repeated for flushing the other oviduct and uterine horn.
The collected medium was transferred to petri dishes and examined for
embryos using a stereomicroscope.
Single blastomere isolation and SNP
genotyping
IVM-IVF, OPU-IVF and in vivo-derived embryos were treated with pronase
(0.1% protease for IVM-IVF and OPU-IVF embryos and 1% protease for
in vivo embryos from S. griseus, Sigma P88110) in Hepes-buffered TCM-
199 (Life Technologies Europe, Belgium) to dissolve zona pellucida. The
zona-free embryos were then washed in HEPES-buffered TCM-199 with
10% FCS followed by Ca+2/Mg+2 free PBS with 0.05% BSA to stimulate
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blastomere dissociation. Next, each blastomere was washed three times
in wash medium (Ca+2/ Mg+2 free PBS with 0.1% polyvinylpyrrolidone)
and subsequently transferred into a 0.2-mL PCR tube containing 2 μl of
PBS and WGA using a commercial multiple displacement amplification kit
according to the manufacturer’s fast 3 h protocol (REPLI-g Single Cell Kit,
Qiagen, Germany). WGA products were purified with SPRI-beads
(Beckman Coulter Inc., USA) at 0.8× total reaction volume and SNP geno-
typed on BovineHD SNP arrays using the Infinium HD whole-genome
genotyping assay. Genotyping data obtained in this study has been submit-
ted to NCBI Gene Expression Omnibus (GEO; accession number
GSE95358; http://www.ncbi.nlm.nih.gov/geo/).
Single blastomere whole-genome analysis
SNP genotypes, logR Ratio (logR) and B Allele Frequency (BAF) values
were obtained for each sample by applying the GenCall algorithm, embed-
ded in the GenomeStudio software Genotyping Module v.3.1 (Illumina
Inc.). SNP genotypes were called by setting the GenCall score at 0.75.
Next, computational workflow ‘siCHILD-bovine’ was used to acquire
genome-wide haplarithm plots for each sample as described previously
(Destouni et al., 2016). Briefly, the acquired single-cell SNP data under-
went quality control (QC) using a combination of unsupervised hierarchical
clustering on the discrete SNP genotype calls and cumulative
chromosome-specific standard deviation on the logR-values. Substandard
samples were excluded from further investigations. The entire process of
haplarithmisis was then applied for data analysis as previously described
(Zamani Esteki et al., 2015). Briefly, haplarithmisis uses single-cell SNP
BAF-values and phased parental genotypes to determine genome-wide
haplotypes, copy-number state of the haplotypes, as well as the parental
and segregational origin of putative haplotype anomalies in the cell. The
parental genotypes are phased via SNP genotype calls derived from a close
relative, e.g. sibling or the grandparents. In this study, we have used pater-
nal and maternal grandparents. Next, specific combinations of phased par-
ental genotypes are retrieved that consequently define single-cell SNP
BAF-values. Consequently, these values are plotted on paternal and
maternal haplarithms. All the haplarithm plots obtained from this study are
provided in Supplementary Figure S3. In parallel with haplarithmisis,
genome-wide haplotypes of single blastomeres were also reconstructed.
Data were visualized with siCHILD, Circos (Krzywinski et al., 2009) and R
(https://www.r-project.org/).
Statistical analysis
Statistical calculations were carried out using GraphPad Prism 6 software
(GraphPad Software Inc., USA). The prevalence of CIN and the nature of
detected chromosomal abnormalities were compared between the three
embryo groups and corresponding single blastomeres by two-tailed
Fisher’s exact test with Bonferroni correction for multiple testing. The dif-
ferences in the frequencies of CIN between the three embryo cohorts
were considered to be statistically significant when the multiple testing cor-
rected P-value was < 0.01. When comparing monospermic embryos, a
P-value <0.05 was considered to be statistically significant.
Results
Embryo collection and genome-wide analysis
of single bovine blastomeres
Five healthy, cycling Holstein Friesian heifers (Bos taurus) were used to
produce IVM-IVF, OPU-IVF and in vivo embryos (Fig. 1A), and the inci-
dence of CIN was evaluated for all three groups. The use of the same
cows and bull seed to study the effect of CIN in vivo and in vitro reduces
potential genetic background confounding effects. First, donor animals
were subjected to varying numbers of ovum pick up sessions depend-
ing on the ovarian response to hormonal stimulation and the number
of oocytes retrieved per session (Table S1). Overall, 49 oocytes were
collected, of which 13 (26.5%, n = 49) were good quality oocytes with
homogeneous non-granulated cytoplasm and at least three compact
layers of cumulus cells. On Day-1 post-insemination (pi), 28 (57.1%,
n = 49) of the presumed zygotes cleaved, and subsequently 77 single
blastomeres were collected from 10 OPU-IVF embryos on Day-2 pi
(median 5.0 blastomeres per embryo) and five OPU-IVF embryos on
Day-3 pi (median 6.0 blastomeres per embryo).
Next, a total of 42 in vivo oviductal-stage embryos were retrieved on
Day-2 pi by oviduct flushing (Besenfelder et al., 2008), from which 34
(81.0%) have cleaved. Due to ovarian stimulation and OPU, the cow
from cross 4757 developed scar tissue and no flushing of in vivo
embryos was possible, because of the obstruction of the oviduct. Of
all the cleaved in vivo embryos, 12 either had indigestible zona pellucida
or lysed during washing and single-cell collection. As a result, 22 zona-
free embryos were collected (median 4.45 blastomeres per embryo)
and 18 were hybridized on SNP arrays after successful amplification of
at least half of the blastomeres per embryo (n = 73).
Following OPU-IVF and in vivo embryo collection, donor animals
were slaughtered, ovaries were collected, and in vitro embryos were
produced (Catteeuw et al., 2017). Thirty-one oocytes were aspirated,
of which 16 (51.6%, n = 31) were of good quality. On Day-1 pi, 20
(64.5%, n = 31) of the presumed zygotes cleaved. Subsequently, 72
blastomeres were isolated from 13 Day-2 pi IVM-IVF embryos (mean
5.54 blastomeres per embryo) and further analyzed.
In summary, a total of 222 individual bovine blastomeres were col-
lected from 13 IVM-IVF, 15 OPU-IVF and 18 in vivo-derived bovine
cleavage-stage embryos. Following QC and initial data analysis, 171
(77.0%, n = 222) blastomeres were considered for further data inter-
pretation (66 blastomeres from 13 IVM-IVF embryos, 46 blastomeres
from 13 OPU-IVF embryos and 59 blastomeres from 16 in vivo-derived
embryos, respectively; Table S2). For crosses 4757, 8301 and 9617
we applied haplarithmisis using both maternal and paternal grandpar-
ents as seeds for parental genotype phasing to reconstruct haplotypes
of single blastomeres (Fig. 1B–C). For crosses 4006 and 4770, lacking
maternal grandparental DNA samples, only parents of the bull were
used as a seed for creating the paternal haplarithm profile.
Characteristics of CIN in embryos developed
in vitro and in vivo
We first aimed to assess the prevalence of CIN in IVM-IVF, OPU-IVF
and in vivo-derived bovine cleavage-stage embryos. To evaluate the
genomic stability of embryos, we investigated chromosome segrega-
tion patterns in all analyzed blastomeres (n = 171, Supplementary
Fig. S1). In this analysis, euploid blastomeres, irrespective of their ploi-
dy, that lacked full chromosome or segmental aberrations were scored
as balanced. The genomic integrity of single blastomeres was higher in
in vivo embryos than in OPU-IVF and IVM-IVF embryos (in both cases
P < 0.0001, Fisher’s exact test; Fig. 2A). At the embryonic level, the
number of abnormal embryos carrying at least one blastomere with a
full or segmental chromosomal aberration increased from 18.8% in
in vivo embryos (3/16) up to 84.6% in IVM-IVF embryos (11/13) (P <
0.001, Fisher’s exact test; Fig. 2B). The CIN rate in OPU-IVF embryos
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(69.2%, 9/13) was comparable to the CIN rate in IVM-IVF embryos
(P > 0.05, Fisher’s exact test), but was higher than in in vivo-derived
embryos (P < 0.01, Fisher’s exact test). Because OPU-IVF group also
contained five Day-3 pi embryos that may have undergone at least one
more cell division that can lead to mitotic error, we decided to analyze
Day-2 pi OPU-IVF embryos (n = 8) separately to obtain more consist-
ency between the groups. Comparison of Day-2 OPU-IVF and in vivo
embryos provided similar results, demonstrating that CIN is higher in
Day-2 pi OPU-IVF embryos (75%, 6/8) than in in vivo-derived Day-2 pi
embryos (P = 0.02, Fisher’s exact test). Likewise, OPU-IVF embryos
contained significantly larger proportion of unbalanced blastomeres
that can subsequently lead to altered embryonic development (16/26,
61.5%, P < 0.0001, Fisher’s exact test).
Next, we determined the nature of chromosomal aberrations in
in vitro-produced and in vivo-derived embryos. As was expected, aneu-
ploidy was the most prevalent type of error and all abnormal in vivo-
derived, OPU-IVF and IVM-IVF embryos contained whole-chromosome
aberrations. Therefore, the number of embryos with aneuploidy was sig-
nificantly higher in OPU-IVF embryos (69.2%, 9/13) and in IVM-IVF
embryos (84.6%, 11/13) than in the in vivo group (18.8%, 3/16, P <
0.01 and P < 0.001, respectively, Fisher’s exact test; Fig. 3A). Meiotic
errors were observed only in Cross 9617, once within the OPU-IVF
group and once within the IVM-IVF group, in which case the embryos
showed the same chromosomal aneuploidy in all of the sister blasto-
meres (OPU-IVF E01_Cross9617 and IVM-IVF E09_Cross9617 were
monosomic for chromosomes 26 and 24, respectively; Supplementary
Fig. S1). The remaining aberrations were of mitotic origin and resulted
in either whole chromosome or segmental imbalances. Segmental
imbalances were most prevalent in IVM-IVF embryos (9/13, 69.2%)
when compared to OPU-IVF embryos (2/13, 15.4%, P = 0.01, Fisher’s
exact test) and in vivo embryos (1/16, 6.3%, P = 0.001, Fisher’s exact
test; Fig. 3A).
We also observed a number of embryos that had at least one
blastomere with an abnormal ploidy state (Fig. 3A). Single-cell hapla-
rithm profiles uncovered the presence of only paternal (androgenetic)
or only maternal (gynogenetic) genomes in a single blastomere and
enabled triploid blastomeres to be classified as diandric or digynic in
origin. Upon comparing IVM-IVF, OPU-IVF and in vivo embryos, we
observed that IVM-IVF embryos were burdened with mixoploidy. In
this study, mixoploidy is defined by the presence of cell lineages of dif-
ferent parental origin and/or different genome-wide ploidy states
within the same embryo. As such, mixoploid embryos harbor simul-
taneously haploid, diploid and/or triploid cells (Fig. 3B, Supplementary
Fig. S1). Mixoploidy in IVM-IVF embryos can be attributed to the dis-
permic fertilization (69.2%, 9/13) that was identified by the presence
of two different paternal haplotypes within the same embryo. In seven
IVM-IVF embryos one of the extra paternal genomes segregated into a
separate androgenetic cell line carrying only paternal DNA, a phenom-
enon that was recently discovered in in vitro-produced bovine
cleavage-stage embryos and termed heterogoneic cell division
(Destouni et al., 2016). For example, a 10-cell IVM-IVF embryo con-
tained eight androgenetic blastomeres, one biparental and one triploid
blastomere (E10_Cross4770, Fig. 3B). In addition, we observed ampli-
fied shattered paternal chromosomal DNA fragments and no maternal
DNA in blastomere Bl005 of E07_Cross4770 (Supplementary Fig. S1),
and in E11_Cross4770 two blastomeres (Bl002 and Bl003) contained
Figure 1 Schematic overview of study design and data analysis. (A) Different protocols used for embryo production. First, five donor cows were
used to obtain OPU-IVF embryos (left). Next, in vivo embryos were derived from the same donor cows via oviduct flush (middle). Finally, donor cows
were slaughtered and IVM-IVF embryos were produced (right). (B) Schematic representation of haplarithm profiles for different genomic rearrange-
ments. During initial parental phasing using informative SNPs, single-cell B allele frequency (BAF) values are assigned to P1 or M1 (blue lines) and P2 or
M2 (red lines) subcategories (for more detail see (Zamani Esteki et al., 2015)). Defined single-cell BAF-values of the segmented P1, P2, M1 and M2, as
well as the distance between the P1-P2 or M1-M2 denote the origin and nature of copy-number (CN) alterations. Dashed gray arrows showing the
pairwise P1-P2 and M1-M2 breakpoints in the haplarithm profiles signify homologous recombination sites, accompanied by the switch in the haplotype
blocks. (C) An example of genome-wide haplarithm profile of single blastomere of OPU-IVF embryo E04 with segmental and full chromosome losses
(light red) and gains (light green), corroborated by the corresponding paternal and maternal haplarithm patterns and the normalized logR-values.
2352 Tšuiko et al.
D
ow
nloaded from
 https://academ
ic.oup.com
/hum
rep/article-abstract/32/11/2348/4191354 by ELN
ET G
roup Account user on 26 February 2019
residues of paternal DNA that were reciprocal in nature
(Supplementary Fig. S1). Such replication and division of the remnants
of sperm genome were also observed in a previous study on bovine
in vitro-produced embryos (Destouni et al., 2016). In contrast, only
one OPU-IVF embryo underwent dispermic fertilization resulting in a
diandric triploid embryo (E03_Cross4757, Fig. S1). Notably, no abnor-
mal fertilization events occurred in the in vivo-derived embryos.
Because dispermy might influence CIN in embryos, we then ana-
lyzed only those embryos that developed from monospermic zygotes.
For this purpose, we combined monospermic IVM-IVF (n = 4) and
OPU-IVF (n = 12) embryos into a single group (referred to as in vitro)
and compared them to in vivo-derived embryos (n = 16). The CIN
rates confirmed a considerable difference between the in vitro-pro-
duced and cultured embryos, and in vivo-derived embryos (10/16,
62.5% vs 3/16, 18.8%, P = 0.03, Fisher’s exact test; Fig. S2A). In add-
ition, it was clear that in vitro procedures had a highly significant nega-
tive impact on CIN, when we compared the low frequency of
chromosomal aberrations and aberrant ploidy states in blastomeres of
in vivo-derived embryos (7/59, 11.9%) with the high frequency
chromosomal aberrations and aberrant ploidy states of in vitro-pro-
duced and cultured embryos (27/57, 47.4%, P < 0.0001, Fisher’s exact
test; Fig. S2B). Similarly, when analyzing only Day-2 pi embryos, seven
in vitro embryos were classified as abnormal (7/11, 63.6%, P = 0.04),
while the total number of abnormal blastomeres in the in vitro group
reached up to 45.9% (17/37, P < 0.001, Fisher’s exact test). Together,
these results strongly suggest that in vitro procedures, such as matur-
ation, fertilization and culture, enhance embryonic CIN and conse-
quently impede embryo developmental potential.
Discussion
Over the past decades, we have witnessed a profound impact of
assisted reproduction on society, as the use of ART continues to
increase globally. The number of women voluntarily or involuntarily
delaying motherhood is also steadily increasing, and for those women,
fertility preservation and IVF procedures are becoming a mainstream
approach to achieve motherhood (Lallemant et al., 2016). In this study,
we applied an advanced genome analysis method to scrutinize the
characteristics of chromosomal aberrations in in vivo-derived embryos
and to investigate the potential influence of ART treatments on the
rate and nature of CIN during early embryo development. We
demonstrated that the genomic stability of in vivo embryos is signifi-
cantly higher compared to OPU-IVF and IVM-IVF embryos.
Because only 30% of human conceptions result in live births
(Macklon et al., 2002) and because chromosomal abnormalities can be
detected in at least half of all spontaneous miscarriages (Menasha
et al., 2005; Levy et al., 2014), it was speculated that post-zygotic
events leading to CIN in IVF embryos would also occur at similar fre-
quency in naturally conceived embryos. However, in contrast to the
initial hypothesis, CIN was found to be significantly more frequent in
in vitro-produced rather that in vivo-derived bovine embryos. Since
CIN was observed in less than 20% of in vivo embryos compared to at
least 70% in in vitro embryos, in vivo-conceived embryos will most likely
be overall more viable. This observation has two major implications:
(i) directing individuals towards ART programs should be done cau-
tiously as it may compromise embryo quality and (ii) improvements to
the embryo in vitro environment are likely still possible to enhance
ART success.
When oocytes are matured in vivo, they originate from ovulatory fol-
licles that undergo strongly regulated processes of selection, growth
and dominance, until LH surge induces the meiotic maturation of the
fully grown oocytes into fertilizable oocytes (Li and Albertini, 2013). In
addition, during preimplantation embryo development in vivo, the
female reproductive tract provides the appropriate environment and
the essential nutrition that guide physiological processes of mammalian
early embryogenesis (Gardner et al., 1996). In contrast, during preim-
plantation embryo development in vitro, even minor alterations during
in vitro culture and the micromanipulation of oocytes and embryos
may negatively impact embryo quality and subsequent fetal develop-
ment (Wale and Gardner, 2016). Indeed, a study in cattle investigated
the separate effect of in vitro procedures (maturation, fertilization and
culture) on embryo developmental potential, and it was clear that
in vivo oocyte maturation and in vivo embryo development show con-
sistently more favorable outcome in terms of embryo quality
Figure 2 The rate of CIN in IVM-IVF, OPU-IVF and in vivo
embryos. The numbers above the columns represent the total num-
bers of blastomeres (A) and embryos (B) included in the study after
QC. (A) The comparison of balanced and unbalanced blastomeres
represents the chromosome dynamics of single blastomeres in IVM-
IVF (n = 66), OPU-IVF (n = 46) and in vivo-derived embryos (n = 59);
****P < 0.0001, two-tailed Fisher’s exact test for multiple testing. (B)
The proportion of normal diploid embryos and aberrant embryos in
IVM-IVF (n = 13), OPU-IVF (n = 13) and in vivo group (n = 16); **P <
0.01, ***P < 0.001, two-tailed Fisher’s exact test for multiple testing.
QC, quality control.
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compared to in vitro conditions (Rizos et al., 2002). Moreover, the
oocyte plays a central role in maintaining genomic integrity before
major embryonic genome activation (EGA), as first post-zygotic divi-
sions are highly dependent on the large pool of maternal mRNAs and
proteins provided by the oocyte (Braude et al., 1988). This view is sup-
ported by the time-lapse study, demonstrating that the generation of
embryonic aneuploidy precedes the major wave of EGA (Chavez
et al., 2012), while the inheritance of an aberrant oocyte transcriptome
has been associated with abnormal first post-zygotic cleavage (Vera-
Rodriguez et al., 2015). Therefore, in the current study, the higher rate
of chromosomal abnormalities in in vitro embryos may also arise from
the defective maternal resources of the oocytes; however more
research should target the precise impact of the intrinsic quality of the
oocyte on the incidence of chromosomal aberrations in cleavage-stage
embryos. Finally, although it was recently demonstrated that mosaic
embryos may be viable, as abnormal cells get depleted during
embryo development, there needs to be a sufficient proportion of
normal cells within the embryo to ensure its survival (Bolton et al.,
2016). Moreover, aneuploid cells in trophectoderm lineage were
proposed to contribute to the formation of confined placental mosai-
cism (Robberecht et al., 2010), a condition that has been associated
with intrauterine growth restriction (Wilkins-Haug et al., 2006; Baffero
et al., 2012).
Controlled ovarian stimulation (COS) is widely used in women to
retrieve numerous oocytes for fertilization per cycle and to enhance
the cumulative pregnancy rate. In humans, COS is considered to be a
safe procedure, since embryo quality, implantation rates and preg-
nancy outcomes are comparable between stimulated and natural IVF
cycles (Ziebe et al., 2004; Sunkara et al., 2016). In our study, although
both in vivo and OPU-IVF embryos were obtained after hormonal
stimulation of donor animals, we observed more chromosomally nor-
mal diploid embryos and blastomeres in in vivo-derived embryos than
in OPU-IVF embryos. This indicates that in vitro maturation, fertiliza-
tion and culture are the major causes of embryonic CIN, rather than
ovarian stimulation itself. This further suggests that improvements in
culture conditions are necessary to increase IVF success rates.
However, there is still an ongoing debate on the potential deleterious
effect of ovarian stimulation on oocyte and embryo quality, so the
technology of human IVM of retrieved oocytes with no or very little
follicle stimulating hormone (FSH) stimulation has been proposed as
an alternative approach to conventional ovarian stimulation followed
by IVF (Dal Canto et al., 2006; Ellenbogen et al., 2014). Although in
humans, achieving pregnancy and live birth via IVM is less successful
than by using conventional IVF (Buckett et al., 2008; Gremeau et al.,
2012), it is a much safer and beneficial option for women with polycys-
tic ovaries or cancer patients for whom hormonal stimulation is con-
traindicated. The main advantage of using IVM in humans is the ability
to eliminate the risk of developing ovarian hyperstimulation syndrome,
a possible life-threatening complication, and to reduce the overall cost
associated with hormonal therapy. In human IVM procedure, subse-
quent oocyte fertilization is typically performed by intracytoplasmic
sperm injection (ICSI), but traditional IVF (human IVM-IVF) has also
been used to fertilize in vitro matured oocytes (Soderstrom-Anttila
et al., 2005; Walls et al., 2012). However, the IVM-IVF combination
may be suboptimal for humans because in vitro matured oocytes have
no contact with the oviductal environment, which enables the oocyte
to reach full cytoplasmic maturation that modifies zona pellucida resist-
ance, and thus zona pellucida of IVM oocytes may become less resist-
ant to dispermic fertilization under in vitro conditions (Xia, 2013). Our
results seem to corroborate this view as dispermic fertilization was
almost exclusively found among IVM-IVF embryos. In addition, we
observed that dispermic embryos segregate their extra paternal gen-
ome into a separate androgenetic cell lineage (Destouni et al., 2016)
leading to mixoploidy. These embryos would have a low developmen-
tal potential, but due to a highly proliferative cell lineage carrying pater-
nal genome only, they would have a higher implantation capacity and
could potentially give rise to molar pregnancies of androgenetic origin.
Complete hydatidiform moles of androgenetic origin have been
reported in both human (Ibrahim et al., 1989; Kwon et al., 2002; Sun
et al., 2012; Obeidi et al., 2015) and in cattle (Meinecke et al., 2002).
Taken together, our results can possibly explain why IVM of human
Figure 3 Incidence and nature of CIN in IVM-IVF, OPU-IVF and
in vivo embryos. (A) The proportion of embryos with different gen-
omic rearrangements. Abnormal ploidy state of blastomeres was not
considered in evaluating whole-chromosome aberrations to avoid
bias; for whole-chromosome aberrations P-values stand as **P < 0.01,
***P < 0.001; for segmental imbalances and aberrant ploidy P-values
stand as **P = 0.01, ***P = 0.001, two-tailed Fisher’s exact test for
multiple testing. (B) Examples of embryos containing at least one
blastomere with an abnormal ploidy status. The stacked bar plots
depict the number of blastomeres with different genomic anomalies
per embryo. Blastomeres with normal karyotype and with single
aneuploidies and/or segmental losses or gains that have both mater-
nal and paternal alleles present in their genome (diploid embryos) are
depicted in black.
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eggs and subsequent IVF and embryo culture are associated with low-
er reproductive success rate (Pfeifer et al., 2013).
Unfortunately, studies of in vivo embryogenesis rely on appropriate
animal models and direct research of in vivo human embryogenesis
awaits novel technical approaches. Another limitation of our study is
the small number of embryos analyzed, and because some of the cells
did not pass the QC, it was also not possible to determine the
chromosomal status of those QC-failed blastomeres. In addition, due
to small cohort sizes, we were not able to compare the pedigrees
between each other to determine any cow-specific confounding fac-
tors, influencing the frequency of aneuploidy in embryos. Thus more
studies are warranted to corroborate our findings. Also, in vivo-derived
embryos do not entirely represent the natural conception, as donor
cows underwent hormonal stimulation to increase the number of
in vivo-derived embryos via oviductal flush. Moreover, the ovarian
response to hormonal treatment is unpredictable and can vary from
cycle to cycle, and may result in either ‘low’ or ‘high’ response to hor-
mone treatment both in cattle (De Roover et al., 2005; Durocher
et al., 2006) and human (Broekmans et al., 2014; Rombauts et al.,
2015). Although the difference in oocyte and embryo quality after
ovarian stimulation between donor animals was also noticed in this
study, future research is needed to evaluate the impact of hormonal
stimulation on CIN in embryos. However, the overall reduced CIN in
in vivo embryos compared to OPU-IVF embryos suggests that the
effect of hormonal stimulation will be minor.
In summary, this is the first study to date that compared simultan-
eously the impact of three different embryo production protocols on
subsequent embryo development using single-cell technologies. We
showed that in vitro environment influence CIN and compromises
cleavage-stage embryo development and survival. This highlights the
importance of understanding in vivo regulation of mammalian oocyte
maturation and subsequent embryonic development to refine assisted
reproductive technologies in human. Some caution to extrapolate the
results to human IVF is required, since oocytes in both OPU-IVF and
IVM-IVF study groups were in vitro matured prior to fertilization. This
procedure is rarely used in human ART. Still, in the absence of human
data, it is of paramount importance to propose ART only to those
couples who have a medical indication for IVF treatment, while the use
of IVF for social reasons should be critically discussed, taking into
account possible complications associated with assisted reproduction.
Supplementary data
Supplementary data are available at Human Reproduction online.
Acknowledgements
The authors thank the CRV Belgium (www.crv4all.be) team for pro-
viding grandparental bovine genotyping data used in this study. We are
grateful to Nathalie Sohier and Eftychia Dimitriadou for technical
assistance.
Authors’ roles
O.T., M.C., M.Z.E., A.V.S. and J.R.V. conceived and designed the
study. M.Z.E. and T.V. developed haplarithmisis. M.C., K.S., O.B.P.,
U.B. and V.H. performed embryo production experiments. O.T. and
M.C. collected single blastomeres and processed samples for SNP-
array hybridization. O.T. and M.Z.E. performed data and statistical
analysis. O.T., M.C., and M.Z.E. wrote the original version of the
manuscript. O.T., M.C., M.Z.E., A.D., U.B., V.H., K.S., A.K., A.S.,
T.D’H., T.V., A.V.S. and J.R.V. wrote and edited the final version of
the manuscript. J.R.V., A.V.S., T.V., A.K. and A.S. provided funding.
A.V.S. and J.R.V. supervised the study.
Funding
The study was funded by the Agency for Innovation by Science and
Technology (IWT) (TBM-090878 to J.R.V. and T.V.), the Research
Foundation Flanders (FWO; G.A093.11N to T.V. and J.R.V. and
G.0392.14N to A.V.S. and J.R.V.), the European Union’s FP7 Marie
Curie Industry-Academia Partnerships and Pathways (IAPP, SARM,
EU324509 to J.R.V., T.V., O.T, A.D., A.S. and A.K.), Horizon 2020
innovation programme (WIDENLIFE, 692065 to J.R.V., O.T., T.V.,
A.K. and A.S.) and Estonian Ministry of Education and Research
(IUT34-16 to A.S.).
Conflict of interest
M.Z.E., J.R.V. and T.V. are co-inventors on a patent application
ZL913096-PCT/EP2014/068315-WO/2015/028576 (‘Haplotyping
and copy-number typing using polymorphic variant allelic frequencies’),
licensed to Cartagenia (Agilent Technologies).
References
Baffero GM, Somigliana E, Crovetto F, Paffoni A, Persico N, Guerneri S,
Lalatta F, Fogliani R, Fedele L. Confined placental mosaicism at chorionic
villous sampling: risk factors and pregnancy outcome. Prenat Diagn 2012;
32:1102–1108.
Besenfelder U, Havlicek V, Moesslacher G, Gilles M, Tesfaye D, Griese J,
Hoelker M, Hyttel PM, Laurincik J, Brem G et al. Endoscopic recovery of
early preimplantation bovine embryos: effect of hormonal stimulation,
embryo kinetics and repeated collection. Reprod Domest Anim 2008;43:
566–572.
Bolton H, Graham SJ, Van der Aa N, Kumar P, Theunis K, Fernandez
Gallardo E, Voet T, Zernicka-Goetz M. Mouse model of chromosome
mosaicism reveals lineage-specific depletion of aneuploid cells and nor-
mal developmental potential. Nat Commun 2016;7:11165.
Braude P, Bolton V, Moore S. Human gene expression first occurs
between the four- and eight-cell stages of preimplantation development.
Nature 1988;332:459–461.
Broekmans FJ, Verweij PJ, Eijkemans MJ, Mannaerts BM, Witjes H.
Prognostic models for high and low ovarian responses in controlled
ovarian stimulation using a GnRH antagonist protocol. Hum Reprod
2014;29:1688–1697.
Buckett WM, Chian RC, Dean NL, Sylvestre C, Holzer HE, Tan SL.
Pregnancy loss in pregnancies conceived after in vitro oocyte matur-
ation, conventional in vitro fertilization, and intracytoplasmic sperm
injection. Fertil Steril 2008;90:546–550.
Catteeuw M, Wydooghe E, Mullaart E, Knijn HM, Van Soom A. In vitro
production of bovine embryos derived from individual donors in the
Corral(R) dish. Acta Vet Scand 2017;59:41.
Chavez SL, Loewke KE, Han J, Moussavi F, Colls P, Munne S, Behr B, Reijo
Pera RA. Dynamic blastomere behaviour reflects human embryo ploidy
by the four-cell stage. Nat Commun 2012;3:1251.
2355Chromosome instability in in vivo and in vitro embryos
D
ow
nloaded from
 https://academ
ic.oup.com
/hum
rep/article-abstract/32/11/2348/4191354 by ELN
ET G
roup Account user on 26 February 2019
Chow JF, Yeung WS, Lau EY, Lee VC, Ng EH, Ho PC. Array comparative
genomic hybridization analyses of all blastomeres of a cohort of embryos
from young IVF patients revealed significant contribution of mitotic
errors to embryo mosaicism at the cleavage stage. Reprod Biol Endocrinol
2014;12:105.
Coates JW, Schmutz SM, Rousseaux CG. A survey of malformed aborted
bovine fetuses, stillbirths and nonviable neonates for abnormal karyo-
types. Can J Vet Res 1988;52:258–263.
Coppola G, Alexander B, Di Berardino D, St John E, Basrur PK, King WA.
Use of cross-species in-situ hybridization (ZOO-FISH) to assess
chromosome abnormalities in day-6 in-vivo- or in-vitro-produced sheep
embryos. Chromosome Res 2007;15:399–408.
Dal Canto MB, Mignini Renzini M, Brambillasca F, Cepparo H, Comi R,
Villa A, Rangoni G, Mastrolilli M, Crippa M, de Ponti E et al. IVM–the first
choice for IVF in Italy. Reprod Biomed Online 2006;13:159–165.
De Roover R, Bols PE, Genicot G, Hanzen C. Characterisation of low,
medium and high responders following FSH stimulation prior to
ultrasound-guided transvaginal oocyte retrieval in cows. Theriogenology
2005;63:1902–1913.
Destouni A, Zamani Esteki M, Catteeuw M, Tsuiko O, Dimitriadou E, Smits
K, Kurg A, Salumets A, Van Soom A, Voet T et al. Zygotes segregate entire
parental genomes in distinct blastomere lineages causing cleavage-stage chi-
merism and mixoploidy. Genome Res 2016;26:567–578.
Diskin MG, Parr MH, Morris DG. Embryo death in cattle: an update.
Reprod Fertil Dev 2012;24:244–251.
Durocher J, Morin N, Blondin P. Effect of hormonal stimulation on bovine
follicular response and oocyte developmental competence in a commer-
cial operation. Theriogenology 2006;65:102–115.
Dyer S, Chambers GM, de Mouzon J, Nygren KG, Zegers-Hochschild F,
Mansour R, Ishihara O, Banker M, Adamson GD. International
Committee for Monitoring Assisted Reproductive Technologies world
report: Assisted Reproductive Technology 2008, 2009 and 2010. Hum
Reprod 2016;31:1588–1609.
Edwards MJ, Park JP, Wurster-Hill DH, Graham JM Jr. Mixoploidy in humans:
two surviving cases of diploid-tetraploid mixoploidy and comparison with
diploid-triploid mixoploidy. Am J Med Genet 1994;52:324–330.
Ellenbogen A, Shavit T, Shalom-Paz E. IVM results are comparable and
may have advantages over standard IVF. Facts Views Vis Obgyn 2014;6:
77–80.
Gardner DK, Lane M, Calderon I, Leeton J. Environment of the preimplan-
tation human embryo in vivo: metabolite analysis of oviduct and uterine
fluids and metabolism of cumulus cells. Fertil Steril 1996;65:349–353.
Gremeau AS, Andreadis N, Fatum M, Craig J, Turner K, McVeigh E, Child
T. In vitro maturation or in vitro fertilization for women with polycystic
ovaries? A case-control study of 194 treatment cycles. Fertil Steril 2012;
98:355–360.
Huang J, Yan L, Fan W, Zhao N, Zhang Y, Tang F, Xie XS, Qiao J.
Validation of multiple annealing and looping-based amplification cycle
sequencing for 24-chromosome aneuploidy screening of cleavage-stage
embryos. Fertil Steril 2014;102:1685–1691.
Ibrahim ZH, Matson PL, Buck P, Atkinson AD, Lieberman BA.
Hydatidiform mole following in-vitro fertilization. Case report. Br J
Obstet Gynaecol 1989;96:1238–1240.
Jarvela IE, Salo MK, Santavuori P, Salonen RK. 46,XX/69,XXX diploid-
triploid mixoploidy with hypothyroidism and precocious puberty. J Med
Genet 1993;30:966–967.
Krzywinski M, Schein J, Birol I, Connors J, Gascoyne R, Horsman D, Jones
SJ, Marra MA. Circos: an information aesthetic for comparative genom-
ics. Genome Res 2009;19:1639–1645.
Kwon HE, Park EJ, Kim SH, Chae HD, Won HS, Kim CH, Kang BM. A case
of twin pregnancy with complete hydatidiform mole and coexisting fetus
following IVF-ET. J Assist Reprod Genet 2002;19:144–148.
Lallemant C, Vassard D, Nyboe Andersen A, Schmidt L, Macklon N.
Medical and social egg freezing: internet based survey of knowledge and
attitudes among women in Denmark and the UK. Acta Obstet Gynecol
Scand 2016;95:1402–1410.
Levy B, Sigurjonsson S, Pettersen B, Maisenbacher MK, Hall MP, Demko Z,
Lathi RB, Tao R, Aggarwal V, Rabinowitz M. Genomic imbalance in pro-
ducts of conception: single-nucleotide polymorphism chromosomal
microarray analysis. Obstet Gynecol 2014;124:202–209.
Li R, Albertini DF. The road to maturation: somatic cell interaction and
self-organization of the mammalian oocyte. Nat Rev Mol Cell Biol 2013;
14:141–152.
Macklon NS, Geraedts JP, Fauser BC. Conception to ongoing pregnancy: the
‘black box’ of early pregnancy loss.Hum Reprod Update 2002;8:333–343.
Maheshwari A, Raja EA, Bhattacharya S. Obstetric and perinatal outcomes
after either fresh or thawed frozen embryo transfer: an analysis of 112,432
singleton pregnancies recorded in the Human Fertilisation and Embryology
Authority anonymized dataset. Fertil Steril 2016;106:1703–1708.
Meinecke B, Kuiper H, Drogemuller C, Leeb T, Meinecke-Tillmann S. A
mola hydatidosa coexistent with a foetus in a bovine freemartin preg-
nancy. Placenta 2002;24:107–112.
Menasha J, Levy B, Hirschhorn K, Kardon NB. Incidence and spectrum of
chromosome abnormalities in spontaneous abortions: new insights from
a 12-year study. Genet Med 2005;7:251–263.
Menezo YJ, Herubel F. Mouse and bovine models for human IVF. Reprod
Biomed Online 2002;4:170–175.
Obeidi N, Tchrakian N, Abu Saadeh F, Mocanu E. Suspected ovarian molar
pregnancy after assisted reproductive technology conception: a diagnostic
challenge. BMJ Case Rep 2015;2015:pii: bcr2015209353. doi: 10.1136/
bcr-2015-209353.
Pfeifer S, Fritz M, Goldberg J, Adamson G, McClure R, Lobo R, Thomas M,
Widra E, Licht M, Collins J et al. In vitro maturation: a committee opin-
ion. Fertil Steril 2013;99:663–666.
Rambags BP, Krijtenburg PJ, Drie HF, Lazzari G, Galli C, Pearson PL,
Colenbrander B, Stout TA. Numerical chromosomal abnormalities in equine
embryos produced in vivo and in vitro.Mol Reprod Dev 2005;72:77–87.
Riegel M, Baumer A, Jamar M, Delbecque K, Herens C, Verloes A,
Schinzel A. Submicroscopic terminal deletions and duplications in
retarded patients with unclassified malformation syndromes. Hum Genet
2001;109:286–294.
Rizos D, Ward F, Duffy P, Boland MP, Lonergan P. Consequences of
bovine oocyte maturation, fertilization or early embryo development
in vitro versus in vivo: implications for blastocyst yield and blastocyst
quality.Mol Reprod Dev 2002;61:234–248.
Robberecht C, Vanneste E, Pexsters A, D’Hooghe T, Voet T, Vermeesch
JR. Somatic genomic variations in early human prenatal development.
Curr Genomics 2010;11:397–401.
Rombauts L, Lambalk CB, Schultze-Mosgau A, van Kuijk J, Verweij P,
Gates D, Gordon K, Griesinger G. Intercycle variability of the ovarian
response in patients undergoing repeated stimulation with corifollitropin
alfa in a gonadotropin-releasing hormone antagonist protocol. Fertil Steril
2015;104:884–890 e882.
Soderstrom-Anttila V, Makinen S, Tuuri T, Suikkari AM. Favourable preg-
nancy results with insemination of in vitro matured oocytes from
unstimulated patients. Hum Reprod 2005;20:1534–1540.
Steptoe PC, Edwards RG. Birth after the reimplantation of a human
embryo. Lancet 1978;2:366.
Sun CJ, Zhao YP, Yu S, Fan L, Wu QQ, Li GH, Zhang WY. Twin pregnancy
and partial hydatidiform mole following in vitro fertilization and embryos
transfer: a novel case of placental mosaicism. Chin Med J (Engl) 2012;
125:4517–4519.
Sunkara SK, LaMarca A, Polyzos NP, Seed PT, Khalaf Y. Live birth and
perinatal outcomes following stimulated and unstimulated IVF: analysis
2356 Tšuiko et al.
D
ow
nloaded from
 https://academ
ic.oup.com
/hum
rep/article-abstract/32/11/2348/4191354 by ELN
ET G
roup Account user on 26 February 2019
of over two decades of a nationwide data. Hum Reprod 2016;31:
2261–2267.
Vanneste E, Voet T, Le Caignec C, Ampe M, Konings P, Melotte C, Debrock
S, Amyere M, Vikkula M, Schuit F et al. Chromosome instability is common
in human cleavage-stage embryos. Nat Med 2009a;15:577–583.
Vanneste E, Voet T, Melotte C, Debrock S, Sermon K, Staessen C,
Liebaers I, Fryns JP, D’Hooghe T, Vermeesch JR. What next for preim-
plantation genetic screening? High mitotic chromosome instability rate
provides the biological basis for the low success rate. Hum Reprod
2009b;24:2679–2682.
Vera-Rodriguez M, Chavez SL, Rubio C, Reijo Pera RA, Simon C.
Prediction model for aneuploidy in early human embryo development
revealed by single-cell analysis. Nat Commun 2015;6:7601.
Viuff D, Hendriksen PJ, Vos PL, Dieleman SJ, Bibby BM, Greve T, Hyttel P,
Thomsen PD. Chromosomal abnormalities and developmental kinetics
in in vivo-developed cattle embryos at days 2 to 5 after ovulation. Biol
Reprod 2001;65:204–208.
Voet T, Vanneste E, Vermeesch JR. The human cleavage stage embryo is a
cradle of chromosomal rearrangements. Cytogenet Genome Res 2011;
133:160–168.
Wale PL, Gardner DK. The effects of chemical and physical factors on
mammalian embryo culture and their importance for the practice of
assisted human reproduction. Hum Reprod Update 2016;22:2–22.
Walls M, Junk S, Ryan JP, Hart R. IVF versus ICSI for the fertilization of in-
vitro matured human oocytes. Reprod Biomed Online 2012;25:603–607.
Wilkins-Haug L, Quade B, Morton CC. Confined placental mosaicism as a
risk factor among newborns with fetal growth restriction. Prenat Diagn
2006;26:428–432.
Xia P. Biology of polyspermy in IVF and its clinical indication. Curr Obstet
Gynecol Rep 2013;2:226–231.
Yamazawa K, Nakabayashi K, Kagami M, Sato T, Saitoh S, Horikawa R,
Hizuka N, Ogata T. Parthenogenetic chimaerism/mosaicism with a
Silver-Russell syndrome-like phenotype. J Med Genet 2010;47:782–785.
Zamani Esteki M, Dimitriadou E, Mateiu L, Melotte C, Van der Aa N,
Kumar P, Das R, Theunis K, Cheng J, Legius E et al. Concurrent whole-
genome haplotyping and copy-number profiling of single cells. Am J Hum
Genet 2015;96:894–912.
Ziebe S, Bangsboll S, Schmidt KL, Loft A, Lindhard A, Nyboe Andersen A.
Embryo quality in natural versus stimulated IVF cycles. Hum Reprod
2004;19:1457–1460.
2357Chromosome instability in in vivo and in vitro embryos
D
ow
nloaded from
 https://academ
ic.oup.com
/hum
rep/article-abstract/32/11/2348/4191354 by ELN
ET G
roup Account user on 26 February 2019
